These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30364124)

  • 1. Cellular and Molecular Immune Response to Chikungunya Virus Infection.
    Tanabe ISB; Tanabe ELL; Santos EC; Martins WV; Araújo IMTC; Cavalcante MCA; Lima ARV; Câmara NOS; Anderson L; Yunusov D; Bassi ÊJ
    Front Cell Infect Microbiol; 2018; 8():345. PubMed ID: 30364124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of immunopathology during chikungunya virus infection.
    Petitdemange C; Wauquier N; Vieillard V
    J Allergy Clin Immunol; 2015 Apr; 135(4):846-855. PubMed ID: 25843597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular mechanisms of chikungunya pathogenesis.
    Lum FM; Ng LF
    Antiviral Res; 2015 Aug; 120():165-74. PubMed ID: 26092642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.
    Fox JM; Diamond MS
    J Immunol; 2016 Dec; 197(11):4210-4218. PubMed ID: 27864552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chikungunya virus pathogenesis and immunity.
    Gasque P; Couderc T; Lecuit M; Roques P; Ng LF
    Vector Borne Zoonotic Dis; 2015 Apr; 15(4):241-9. PubMed ID: 25897810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.
    Clayton AM
    J Infect Dis; 2016 Dec; 214(suppl 5):S506-S509. PubMed ID: 27920182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology of Chikungunya Virus Infection: Lessons Learned from Patients and Animal Models.
    Ng LFP
    Annu Rev Virol; 2017 Sep; 4(1):413-427. PubMed ID: 28637387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chikungunya Virus: Current Perspectives on a Reemerging Virus.
    Morrison CR; Plante KS; Heise MT
    Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive immunoinformatics and target site study revealed the corner-stone toward Chikungunya virus treatment.
    Hasan MA; Khan MA; Datta A; Mazumder MH; Hossain MU
    Mol Immunol; 2015 May; 65(1):189-204. PubMed ID: 25682054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Vaccines for Chikungunya Fever.
    Erasmus JH; Rossi SL; Weaver SC
    J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.
    Seymour RL; Adams AP; Leal G; Alcorn MD; Weaver SC
    PLoS Negl Trop Dis; 2015; 9(6):e0003800. PubMed ID: 26115459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.
    Roques P; Ljungberg K; Kümmerer BM; Gosse L; Dereuddre-Bosquet N; Tchitchek N; Hallengärd D; García-Arriaza J; Meinke A; Esteban M; Merits A; Le Grand R; Liljeström P
    JCI Insight; 2017 Mar; 2(6):e83527. PubMed ID: 28352649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress on chikungunya virus research.
    An W; Ge N; Cao Y; Sun J; Jin X
    Virol Sin; 2017 Dec; 32(6):441-453. PubMed ID: 29188427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.
    de Lima Cavalcanti TYV; Pereira MR; de Paula SO; Franca RFO
    Viruses; 2022 May; 14(5):. PubMed ID: 35632709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chikungunya virus pathogenesis: From bedside to bench.
    Couderc T; Lecuit M
    Antiviral Res; 2015 Sep; 121():120-31. PubMed ID: 26159730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
    Amdekar S; Parashar D; Alagarasu K
    Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
    Chua CL; Sam IC; Merits A; Chan YF
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.
    Wu J; Zhao C; Liu Q; Huang W; Wang Y
    Vaccine; 2017 Nov; 35(47):6387-6394. PubMed ID: 29031692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic strategies to control chikungunya virus infection.
    Hucke FIL; Bestehorn-Willmann M; Bugert JJ
    Virus Genes; 2021 Apr; 57(2):133-150. PubMed ID: 33590406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of research and development of vaccines for chikungunya.
    Smalley C; Erasmus JH; Chesson CB; Beasley DWC
    Vaccine; 2016 Jun; 34(26):2976-2981. PubMed ID: 27026149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.